http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210107385-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_441f7c6829d19d1f693aa6ad677f2e8d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 2020-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7ff59751da1f12e4c55de7ef5bac928 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1c44093f762a4606abadaea8fe36107 |
| publicationDate | 2021-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210107385-A |
| titleOfInvention | Pharmaceutical composition for preventing or treating cancer stem cell marker expression cancer diseases comprising epidermal growth factor-like domain 8 |
| abstract | The present invention relates to a composition for preventing or treating cancer stem cell marker-expressing cancer diseases containing epidermal growth factor-like domain 8 or an activator thereof as an active ingredient. Epidermal growth factor-like domain 8 (EGFL8) in malignant ovarian cancer cells that induce Domain 8 (EGFL8) or an activator thereof may serve as a therapeutic agent for a malignant cancer disease. |
| priorityDate | 2020-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 570.